New Eye Vitamin Supplement to Prevent Macular Degeneration

October 21, 2007 (PRLEAP.COM) Health News
Huntington, New York (US) October 21, 2007 — Huntington, New York based Vitamin Science Inc. has launched a unique supplement for the prevention of disease progression in the eyes and improvement of vision. VisiVite AREDS-2 Macular Degeneration Formula this new product is the first and only one to offer this unique supplement.

VisiVite AREDS-2 Formula is based upon the prediction of the most successful components and modifications of the ongoing Age Related Eye Disease Study 2 (AREDS-2) now being conducted by The National Institutes of Health. AREDS-2 is the newest and most advanced Macular Degeneration Formula Study.

VisiVite AREDS-2 Formula is recommended for the following patients with macular degeneration: (1) progressive macular degeneration with vision loss in one or both eyes, (2) presence in the retina of large drusen, pigmentation or geographic atrophy. It is safe for both smokers and non-smokers (does not contain beta-carotene).

This product will be available from October 19, 2007 at the sales price of $39.95.

All orders from VisiVite.Com are received and processed in real time, and are shipped on the same business day or next business day. Yahoo's secure 128-bit encrypted servers ensure the safety of your identity and credit card information.

About VisiVite: is the online store of Vitamin Science Inc.

Vitamin Science was founded in 2001 by a panel of New York ophthalmic surgeons. It is based in Huntington, New York, and manufactures vitamin supplements to treat ocular diseases. Its products are manufactured as per the recommendations of the National Eye Institute, which is part of the United States National Institutes of Health.

All the Vitamin Science products are exclusively manufactured by Nature's Value Laboratory in Coram, New York a laboratory which is certified by the National Nutritional Food Association's (NNFA) Good Manufacturing Practices (GMP) Program.

For further information please contact:
Nancy Golinko, V.P.
1-800-427-7660, Ext 4